WEIGHT LOSS
Weight Loss Injections on the NHS vs Private Care
How NHS and private routes compare for weight loss treatment, what private care can offer beyond speed, and why clinical standards still apply.
Patients considering GLP-1 medicines such as Mounjaro or Wegovy often want to understand how the NHS and private routes compare — not just in terms of speed, but in terms of clinical standards, monitoring, and what the appointment actually involves. Both routes should involve proper medical assessment. The difference usually lies in access, time, continuity, and how treatment is coordinated alongside broader health concerns.
Private care can offer something beyond speed — but both routes should meet the same clinical standards, and patients deserve an honest picture of what each involves.
ON THIS PAGE
How the NHS weight loss pathway works
NHS access to GLP-1 medicines is governed by national guidance (NICE) and local commissioning arrangements, which vary by area. Eligibility typically requires a BMI of 35 or above (or 30+ with significant weight-related comorbidity), engagement with a tier 2 or tier 3 weight-management service, and a referral from a GP. In practice, this means patients often need to complete a structured lifestyle programme before medication is considered. Waiting times vary significantly.
The NHS pathway has genuine strengths: it is free at the point of use, it is structured, and the eligibility criteria help ensure medication is directed towards patients who are most likely to benefit. The limitations are primarily around access — speed, appointment time, and the degree of individual clinical discussion that busy services can offer.
What private care offers differently
Private weight-loss care typically provides faster access to assessment and prescribing, longer consultations (30 minutes as standard at Basuto), baseline blood testing before treatment begins, continuity with a named doctor, and the ability to coordinate weight management alongside related services such as menopause review, men’s health, metabolic screening or counselling — all from the same practice.
The cost is the main consideration. A GP consultation is £150, medication is paid for separately, and ongoing monitoring requires follow-up appointments. For patients who expect to need regular reviews, membership can make this more cost-effective.
Private route
When private care makes the most sense
Private care is usually most worthwhile when patients want to start the assessment process promptly rather than waiting months for an NHS referral, when they value longer appointments and more detailed clinical discussion, when weight management overlaps with other concerns (hormonal change, cardiovascular risk, medication review, mental health), or when they want a doctor who can monitor treatment response, adjust dosing, and coordinate follow-up without fragmentation between separate services.
Same-day appointments available. Book online or call 020 7736 7557.
Standards
Clinical standards should be the same regardless of route
Whether a patient accesses weight-loss medication through the NHS or privately, the clinical standards should be equivalent. That means proper assessment before prescribing, baseline blood tests where appropriate, discussion of contraindications and side effects, gradual dose titration, structured follow-up, and ongoing monitoring of safety and response. At Basuto, the weight loss pathway includes all of these steps as standard.
Common questions
What does the NHS GLP-1 pathway involve?
NHS access is governed by NICE and local commissioning. Eligibility typically requires a BMI of 35 or above (or 30+ with significant weight-related comorbidity), engagement with a tier 2 or tier 3 weight-management service, and a GP referral. Waiting times vary. The pathway is free at the point of use, structured, and directed towards patients most likely to benefit.
What does private care genuinely offer beyond speed?
Faster assessment and prescribing, 30-minute consultations, baseline bloods before treatment, continuity with a named GP, and coordination with related services (menopause, men’s health, metabolic screening, counselling) from the same practice. Cost is the main trade-off — consultations at £150, medication priced separately, and ongoing follow-up appointments.
Should clinical standards differ between NHS and private routes?
No. Whichever route a patient uses, the clinical standards should be equivalent: proper assessment before prescribing, baseline bloods where appropriate, discussion of contraindications and side effects, gradual titration, structured follow-up, and ongoing monitoring of safety and response.
FURTHER READING